Dr. Samlowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9280 W Sunset Road
Suite 100
Las Vegas, NV 89148Phone+1 702-952-1251Fax+1 702-952-1241- Is this information wrong?
Education & Training
- University of Utah HealthFellowship, Hematology and Medical Oncology, 1981 - 1984
- Wayne State University School of MedicineResidency, Internal Medicine, 1978 - 1981
- Ohio State University College of MedicineClass of 1978
Certifications & Licensure
- UT State Medical License 1981 - 2026
- NV State Medical License 2007 - 2025
- MI State Medical License 1979 - 1984
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Start of enrollment: 1999 Nov 01
- S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Start of enrollment: 2003 Oct 01
- Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2009 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC mel...Michelle A Silver, Andriana Hohlbauch, Shujing Zhang, Mizuho Fukunaga-Kalabis, Clemens Krepler, Yunfei Wang, Ila Sruti, Ruixuan Jiang, Wolfram Samlowski> ;Melanoma Research. 2024 May 27
- The Effect of Non-Overlapping Somatic Mutations in,,, oron the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melan...Samlowski, W.> ;Cancers. 2024 Jan 30
- Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report.Claire V Ong, Wolfram Samlowski> ;Frontiers in Oncology. 2024 Jan 1
- Join now to see all
Press Mentions
- Introducing Vegas Inc’s 2021 Top DoctorsAugust 26th, 2021
- Health Care Quarterly’s 2020 Top DoctorsAugust 20th, 2020
Grant Support
- Epigenetic Potentiation Of Interferon Using DecitabineNational Cancer Institute2007–2008
- Phase I Trial Of Php With High-Dose IL-2National Cancer Institute2006
- Phase I Trial Of Php With High-Dose IL-2National Cancer Institute2005–2006
- Southwest Oncology Group (UTAH)National Cancer Institute1993–2003
- Toxicity Of Continuous Infusion N Acetyl Cysteine With High Dose IL2National Center For Research Resources1998–2002
- Nitric Oxide As A Tumor DefenseNational Cancer Institute1997–1999
- Toxicity Of Continuous Infusion N-Acetyl Cysteine With High Dose IL-2National Center For Research Resources1995–1997
- Phase II Trial--Il-2 Treatment Of Relapsed Or Refractory ANLLNational Center For Research Resources1996
- FACS Vantage Cell SorterNational Center For Research Resources1995
- Use Of Sulfhydryl Compounds To Increase IL-2 ActivityNational Cancer Institute1992–1994
- Endothelial Cell Toxicity Of Marrow Ablative AgentsNational Cancer Institute1988–1992
Professional Memberships
- Member
Hospital Affiliations
- Southern Hills Hospital and Medical CenterLas Vegas, Nevada
- St. Rose Dominican Hospitals - San Martin CampusLas Vegas, Nevada
- Spring Valley Hospital Medical CenterLas Vegas, Nevada
- North Las Vegas VA Medical CenterNorth Las Vegas, Nevada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: